178 related articles for article (PubMed ID: 18985310)
1. Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154.
Deambrosis I; Lamorte S; Giaretta F; Tei L; Biancone L; Bussolati B; Camussi G
J Mol Med (Berl); 2009 Feb; 87(2):181-97. PubMed ID: 18985310
[TBL] [Abstract][Full Text] [Related]
2. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction.
Wagner AH; Güldenzoph B; Lienenlüke B; Hecker M
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):715-20. PubMed ID: 14976003
[TBL] [Abstract][Full Text] [Related]
3. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
4. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.
Gong YF; Xiang LX; Shao JZ
J Immunol; 2009 Jun; 182(12):7749-62. PubMed ID: 19494299
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
Green KA; Noelle RJ; Durell BG; Green WR
J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
[TBL] [Abstract][Full Text] [Related]
7. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.
Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G
Int J Immunopathol Pharmacol; 2006; 19(1):81-96. PubMed ID: 16569346
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction.
Russo S; Bussolati B; Deambrosis I; Mariano F; Camussi G
J Immunol; 2003 Nov; 171(10):5489-97. PubMed ID: 14607955
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
11. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
Zhu B; Liu Z; Wang P; Wu C; Xu H
Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
[TBL] [Abstract][Full Text] [Related]
12. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
13. Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation.
Néron S; Nadeau PJ; Darveau A; Leblanc JF
Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):25-40. PubMed ID: 21234809
[TBL] [Abstract][Full Text] [Related]
14. High sequence homology between human and pig CD40 with conserved binding to human CD154.
Rushworth SA; Bravery CA; Thompson S
Transplantation; 2000 Mar; 69(5):936-40. PubMed ID: 10755553
[TBL] [Abstract][Full Text] [Related]
15. Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.
Edelmann KH; Wilson CB
J Virol; 2001 Jan; 75(2):612-21. PubMed ID: 11134274
[TBL] [Abstract][Full Text] [Related]
16. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
Zhu ZX; Fan LY; Wang Q
Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
[TBL] [Abstract][Full Text] [Related]
18. The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis.
Lee VW; Qin X; Wang Y; Zheng G; Wang Y; Wang Y; Ince J; Tan TK; Kairaitis LK; Alexander SI; Harris DC
Nephrol Dial Transplant; 2010 Mar; 25(3):717-30. PubMed ID: 19889873
[TBL] [Abstract][Full Text] [Related]
19. A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions.
Barnhart B; Ford GS; Bhushan A; Song C; Covey LR
Immunology; 2000 Jan; 99(1):54-61. PubMed ID: 10651941
[TBL] [Abstract][Full Text] [Related]
20. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]